Prevalence of previously unknown elevation of glycosylated hemoglobin in spine surgery patients and impact on length of stay and total cost
Authors:
- M. Sami WalidMWM. Sami Walid
- Brooke F. NewmanBNBrooke F. Newman
- Joshua C. YelvertonJYJoshua C. Yelverton
- Jonathan P. NutterJNJonathan P. Nutter
- Mohammed AjjanMAMohammed Ajjan
- Joe Sam RobinsonJRJoe Sam Robinson
- 14 September 2009
- journal article
- research article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 5 (1) , E10-4
Abstract
BACKGROUND: Elevated levels of glycosylated hemoglobin (HbA1c) among spine surgery patients may have an impact on length of stay (LOS) and healthcare cost.MATERIALS AND METHODS: We retrospectively reviewed the charts of 556 spine surgery patients who underwent 1 of 3 types of surgery: lumbar microdiscectomy (LMD), anterior cervical decompression and fusion (ACDF), and lumbar decompression and fusion (LDF). Information was collected about their diabetes mellitus (DM) history and HbA1c levels. We used HbA1c 6.1% as the screening cutpoint. Percentages of nondiabetic patients, those with subclinical elevation of HbA1c and those with already known DM were calculated and statistical analysis was applied.RESULTS: After excluding the small group of well‐controlled DM (n = 14), 72.4% of patients were nondiabetic, 14.3% were subclinical patients with previously unknown HbA1c elevation, and 13.3% were already known, confirmed DM patients. There were significant differences in the LDF group between the “No DM” and “Subclinical” groups (P < 0.05) in terms of cost and LOS (P < 0.05). Age and body mass index (BMI) were very significant predictors of total cost in spine surgery patients (P ≤ 0.001), in addition to the type of surgery. Univariate analysis with age, BMI, or both as covariates deprived DM‐HbA1c status of statistical significance (P > 0.05) in determining cost.CONCLUSIONS: There is a significant segment of spine surgery patients who were unaware of their elevated HbA1c status before their preoperative visit. These patients seem to utilize more healthcare resources, which is especially evident in the LDF group. We believe that HbA1c should be considered in the routine preoperative workup of spine surgery patients. Journal of Hospital Medicine 2010;5:E10–E14. © 2010 Society of Hospital Medicine.Keywords
This publication has 15 references indexed in Scilit:
- Causes and Risk Factors for Postoperative Fever in Spine Surgery PatientsSouthern Medical Journal, 2009
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarctionAmerican Heart Journal, 2007
- Diabetes and Early Postoperative Outcomes Following Lumbar FusionSpine, 2007
- HbA1c as a screening tool for detection of Type 2 diabetes: a systematic reviewDiabetic Medicine, 2007
- The influence of age and body mass index on the metabolic syndrome and its componentsDiabetes, Obesity and Metabolism, 2007
- Standards of Medical Care in Diabetes—2007Diabetes Care, 2007
- Impact of Recent Increase in Incidence on Future Diabetes BurdenDiabetes Care, 2006
- Utility of hemoglobin A1c in predicting diabetes riskJournal of General Internal Medicine, 2004
- Eating, exercise, and “thrifty” genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseasesJournal of Applied Physiology, 2004